Advantage Alpha Capital Partners’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21,798
Closed -$3.27M 130
2025
Q3
$3.27M Buy
21,798
+511
+2% +$80.5K 0.99% 45
2025
Q2
$3.39M Buy
+21,287
New +$3.45M 0.91% 64
2024
Q4
Sell
-12,405
Closed -$2.18M 182
2024
Q3
$2.18M Sell
12,405
-5,346
-30% -$910K 0.5% 76
2024
Q2
$2.73M Sell
17,751
-6,082
-26% -$916K 0.6% 64
2024
Q1
$3.69M Sell
23,833
-5,830
-20% -$864K 0.69% 64
2023
Q4
$4.41M Buy
+29,663
New +$3.79M 0.84% 57
2021
Q4
Sell
-27,522
Closed -$3.99M 140
2021
Q3
$3.99M Buy
27,522
+475
+2% +$64.3K 0.73% 74
2021
Q2
$3.55M Sell
27,047
-2,745
-9% -$353K 0.68% 77
2021
Q1
$3.74M Sell
29,792
-8,578
-22% -$1.04M 0.79% 67
2020
Q4
$4.42M Sell
38,370
-32,344
-46% -$3.41M 0.97% 51
2020
Q3
$6.9M Buy
70,714
+12,050
+21% +$1.18M 1.6% 20
2020
Q2
$5.57M Buy
58,664
+24,269
+71% +$2.27M 1.3% 30
2020
Q1
$3.4M Buy
34,395
+3,605
+12% +$369K 1.21% 35
2019
Q4
$3.13M Buy
+30,790
New +$3.11M 0.84% 64

Other funds holding BCPC

Advantage Alpha Capital Partners's BCPC Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of Balchem Corp (BCPC) in Q4 2025, closing a stake of 21,798 shares — an estimated $3.27M sold.

Advantage Alpha Capital Partners first reported a position in BCPC in Q4 2019 and held it in 14 quarters. The position peaked at $6.9M in Q3 2020. 409 funds tracked by Wall St. Rank hold BCPC as of Q4 2025.

  • Advantage Alpha Capital Partners reported no remaining Balchem Corp position as of Q4 2025 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 21,798 Balchem Corp shares in Q4 2025, an estimated $3.27M.
  • Advantage Alpha Capital Partners first reported a position in Balchem Corp in Q4 2019 and held it in 14 quarters.
  • Advantage Alpha Capital Partners's Balchem Corp position peaked at $6.9M in Q3 2020.
  • 409 funds tracked by Wall St. Rank held Balchem Corp as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.